Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
BMS Gains European Approval for Opdivo Subcutaneous Formulation
CompanyDrug

BMS Gains European Approval for Opdivo Subcutaneous Formulation

May 29, 2025
Novartis' Fabhalta Approved for Previously Treated PNH Patients in China
CompanyDrug

Novartis’ Fabhalta Approved for Previously Treated PNH Patients in China

May 29, 2025
InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248
CompanyDrug

InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248

May 29, 2025
Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets
CompanyDeals

Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets

May 29, 2025
Lupeng Pharma's Rocbrutinib Near Approval for Mantle Cell Lymphoma
CompanyDrug

Lupeng Pharma’s Rocbrutinib Near Approval for Mantle Cell Lymphoma

May 29, 2025
Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects
CompanyDeals

Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects

May 29, 2025
Bayer's Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC
CompanyDrug

Bayer’s Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC

May 29, 2025
JW Therapeutics' Carteyva Receives Fourth sBLA for r/r LBCL
CompanyDrug

JW Therapeutics’ Carteyva Receives Fourth sBLA for r/r LBCL

May 29, 2025
Sino Medical Sciences Technology's AUCURA Flow-Diverting Stent Approved by NMPA
CompanyMedical Device

Sino Medical Sciences Technology’s AUCURA Flow-Diverting Stent Approved by NMPA

May 29, 2025
Changchun Pharma Wins FDA Approval for GenSci128 in TP53 Y220C Solid Tumors
CompanyDrug

Changchun Pharma Wins FDA Approval for GenSci128 in TP53 Y220C Solid Tumors

May 29, 2025
Yantai Dongcheng Pharma Gains NMPA Approval for Sodium Fluoride [18F]
CompanyDrug

Yantai Dongcheng Pharma Gains NMPA Approval for Sodium Fluoride [18F]

May 28, 2025
Explore the latest insights on Yaohua Medical Instrument and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Yaohua Medical Instrument's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.
CompanyDeals

Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization

May 28, 2025
1 2 … 149 150 151 152 153 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up